Best peptides for Weight Loss

GLP-1 receptor agonist | Type 2 diabetes and obesity

### Semaglutide Summary Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that has been investigated for its role in managing type 2 diabetes and obesity. Its efficacy in promoting weight loss and improving glycemic control has garnered significant attention in recent clinical research.

Essential Cellular Coenzyme & Anti-Aging Therapy

### Summary NAD+ (Nicotinamide adenine dinucleotide) is a crucial coenzyme involved in various metabolic processes, including energy production and cellular repair mechanisms. Recent research highlights its potential roles in protecting against oxidative stress and enhancing therapeutic efficacy in certain cancer treatments.

Mitochondrial-Targeted Peptide | Cardiolipin Protector

### Summary SS-31, also known as Elamipretide, is a peptide that has garnered attention for its potential role in mitochondrial protection and its implications in various health conditions, particularly those involving oxidative stress and mitochondrial dysfunction.

Metabolic regulation | Vascular health

### Summary PE 22-28 is a peptide that has garnered attention in various research contexts, particularly in relation to vascular health and metabolic conditions. Its potential implications in gestational diabetes and placental function are areas of ongoing investigation.

GIP/GLP-1 Agonist | Type 2 Diabetes and Obesity

### Summary Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that has been investigated for its potential in managing type 2 diabetes and obesity. Its unique mechanism of action aims to enhance glycemic control and promote weight loss.

EPO | Red Blood Cell Stimulating Hormone

Erythropoietin (EPO) is a glycoprotein hormone that stimulates red blood cell production in bone marrow, used clinically for anemia and studied in hematology and metabolic research.

Mitochondrial-Derived Peptide | Metabolic Regulator

### Summary MOTS-C is a mitochondrial-derived peptide that has garnered attention for its potential roles in metabolic regulation and cellular stress responses. Emerging research suggests it may have implications in various health conditions, including cardiovascular diseases and placental function.

Human Growth Hormone | Somatropin

HGH (somatropin) is recombinant human growth hormone, FDA-approved for pediatric and adult GH deficiency and several wasting and short-stature conditions; widely studied for body composition off-label.

GHRH Analog | Visceral Fat Reduction

### Tesamorelin Summary Tesamorelin is a synthetic peptide that functions as a growth hormone-releasing hormone (GHRH) analog, primarily investigated for its potential to reduce visceral fat in individuals with HIV-associated lipodystrophy. Its role in metabolic health and body composition continues to be explored in various clinical contexts.

Ghrelin Receptor Agonist | Oral Growth Hormone Secretagogue

### Summary MK-677, also known as Ibutamoren, is a growth hormone secretagogue that has garnered attention for its potential effects on muscle mass and body composition. Research is ongoing to better understand its mechanisms and applications in various contexts, including its detection in biological samples.

Examorelin | Synthetic Growth Hormone Secretagogue

### Hexarelin Summary Hexarelin is a synthetic hexapeptide that belongs to the growth hormone secretagogue (GHS) class, known for its ability to stimulate growth hormone release from the pituitary gland. It has been investigated for its potential therapeutic applications in various conditions, including muscle wasting and age-related decline in growth hormone levels.

Growth Hormone Releasing Peptide-6 | Hexapeptide GHS

GHRP-6 is a synthetic hexapeptide growth hormone secretagogue that stimulates pituitary GH release via the ghrelin receptor and is widely studied as a research GHS.

Stimulates GLP-1 secretion | Appetite regulation

### Summary GLP-1 blends refer to combinations of glucagon-like peptide-1 (GLP-1) analogs or related compounds that may enhance the secretion of this hormone, which plays a critical role in glucose metabolism and appetite regulation. Recent research has explored various natural extracts and dietary components that may influence GLP-1 secretion and its physiological effects.

Growth Hormone Releasing Peptide-2 | Pralmorelin

GHRP-2 (pralmorelin) is a synthetic hexapeptide and ghrelin-receptor agonist studied as a growth hormone secretagogue, used clinically as a diagnostic agent and investigationally for GH-related research.

Gene expression modulation | Liver support

Ovagen (EDL) is a Khavinson-family tripeptide bioregulator researched for liver and gastrointestinal tissue support, proposed to act via gene-expression modulation in hepatocytes and enterocytes.

GHRH Analog | Growth Hormone Releasing Hormone

### Summary Sermorelin is a synthetic peptide that mimics growth hormone-releasing hormone (GHRH), stimulating the pituitary gland to produce and release endogenous growth hormone. It has been investigated for its potential therapeutic applications, particularly in the context of growth hormone deficiencies and other related conditions.

Triple reuptake inhibitor | Weight management

### Summary Tesofensine is a novel compound initially developed as an antidepressant, which has gained attention for its potential effects on weight loss and metabolic regulation. Research indicates that it may influence neurotransmitter levels, thereby affecting appetite and energy expenditure.

Mitochondrial uncoupler | Obesity treatment

BAM-15 is a mitochondrial protonophore uncoupler studied preclinically for obesity, insulin resistance, and metabolic dysfunction by increasing energy expenditure without raising heart rate.

Long-Acting Amylin Receptor Agonist | Weight Loss & Diabetes

Cagrilintide (AM833) is a long-acting amylin analog investigated for once-weekly subcutaneous use in obesity and type 2 diabetes, most notably combined with semaglutide as CagriSema.

Amino Acid Derivative | Fatty Acid Transporter

L-Carnitine (levocarnitine) is an amino acid derivative that shuttles long-chain fatty acids into mitochondria for energy production, studied for metabolic, cardiovascular, and exercise performance applications.

Modified hGH Fragment | Fat Loss Peptide

A GH-fragment–derived peptide primarily discussed for fat loss and body-composition change, sometimes with cartilage and joint-repair context.

Dual GLP-1/Glucagon Receptor Agonist | Weight Loss & Diabetes

Mazdutide (IBI362) is an investigational dual GLP-1/glucagon receptor agonist studied for weight loss and type 2 diabetes, combining appetite suppression with increased energy expenditure.

Growth Hormone Secretagogue | Selective GHRP

### Summary Ipamorelin is a synthetic peptide that acts as a selective agonist of the growth hormone secretagogue receptor, primarily stimulating growth hormone release. Its potential therapeutic applications are being explored in various contexts, including weight management and pain modulation.

NNMT Inhibitor | Longevity & Metabolic Enhancement

Research-peptide often discussed for body recomposition: weight-loss–focused with muscle preservation, cholesterol and inflammation effects.

5-Aminoimidazole-4-carboxamide Ribonucleotide | AMPK Activator

AICAR (Acadesine) is a small-molecule AMPK activator studied for metabolic, endurance, and cardioprotective effects. It mimics AMP to shift cells toward energy-producing pathways.

Stimulates GH release | Potential metabolic benefits

### Summary GH secretagogue blends are formulations designed to stimulate the secretion of growth hormone (GH) from the pituitary gland. These blends typically consist of various peptides and compounds that may enhance GH release, potentially influencing growth, metabolism, and overall health.

Lipolytic action | Fat loss

HGH Fragment 176–191, a GH-derived peptide discussed primarily for fat loss and bone/sleep effects.

Long-Acting Growth Hormone Releasing Hormone Analog | Extended Release

CJC-1295 with DAC is a long-acting GHRH analog bound to serum albumin, studied as an investigational growth hormone secretagogue with a multi-day half-life and sustained IGF-1 elevation.

Growth Hormone Fragment | Fat Loss Peptide

HGH Fragment 176-191 is a synthetic C-terminal fragment of human growth hormone studied for its lipolytic (fat-burning) effects without the growth-promoting actions of full GH.

Oral Small-Molecule GLP-1 Receptor Agonist | Weight Loss & Diabetes

Orforglipron (LY-3502970) is an investigational oral small-molecule GLP-1 receptor agonist studied for type 2 diabetes and obesity, offering pill-based dosing without injection.

KEDW Tetrapeptide | Pancreas Bioregulator

Pancragen (KEDW) is a synthetic tetrapeptide bioregulator studied for pancreatic endocrine support, glucose-insulin modulation, and longevity applications in preclinical and small human studies.

Prohibitin-Targeting Peptidomimetic | Experimental Anti-Obesity

Adipotide (Prohibitin-TP01) is an experimental peptidomimetic that targets prohibitin on white adipose vasculature to trigger fat-supply regression, studied preclinically for obesity.

Short-Acting Growth Hormone Releasing Hormone Analog

CJC-1295 without DAC (Modified GRF 1-29) is a short-acting GHRH analog studied for its ability to stimulate pulsatile growth hormone release from the pituitary.

GHRH/GHRP Combination | Growth Hormone Optimization

CJC-1295/Ipamorelin is a research peptide stack pairing a GHRH analog with a selective ghrelin receptor agonist to amplify endogenous growth hormone release.

Four-Peptide Regenerative Blend

KLOW is a four-peptide compounded blend (typically KPV, LL-37, GHK, and Wolverine-style healing peptides) studied informally for combined regenerative and metabolic effects.

GLP-1 analog | Type 2 diabetes management

Research peptide discovered via AI researcher. peptide-based therapeutic

Melanocortin receptor agonist | Weight management

Research peptide discovered via AI researcher. peptide-based therapeutic

Mitochondrial function | Potential therapeutic

Research peptide discovered via AI researcher. peptide-based therapeutic

Glucose regulation | Diabetes management

Research peptide discovered via AI researcher. peptide-based therapeutic

GnRH Agonist | Hormone modulation

Research peptide discovered via AI researcher. peptide analogue

GLP-1 Agonist | Type 2 Diabetes Management

Research peptide discovered via AI researcher. peptide-based therapeutic

Water retention | Diabetes insipidus

Research peptide discovered via AI researcher. peptide-based therapeutic

GLP-1 Agonist | Type 2 Diabetes Management

Research peptide discovered via AI researcher. peptide-based therapeutic

Metabolic regulation | Potential role in glucose metabolism

Research peptide discovered via AI researcher. research peptide

Antidiuretic | Fluid balance regulation

Research peptide discovered via AI researcher. peptide-based therapeutic

GnRH Agonist | Hormone-sensitive conditions

Research peptide discovered via AI researcher. peptide analogue